 | • レポートコード：QYR2104Z2854 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ヒストプラズマ症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アムホテリシンB、イトラコナゾール、ケトコナゾール、その他）、用途別市場規模（病院薬局、私立クリニック、ドラッグストア・小売薬局、Eコマース）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒストプラズマ症治療の市場動向 ・企業の競争状況、市場シェア ・ヒストプラズマ症治療の種類別市場規模（アムホテリシンB、イトラコナゾール、ケトコナゾール、その他） ・ヒストプラズマ症治療の用途別市場規模（病院薬局、私立クリニック、ドラッグストア・小売薬局、Eコマース） ・ヒストプラズマ症治療の北米市場規模2016-2027（アメリカ、カナダ） ・ヒストプラズマ症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒストプラズマ症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒストプラズマ症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒストプラズマ症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol Myers Squibb、Sigma tau pharmaceuticals Inc.、Three rivers pharmaceuticals、Astellas pharma US Inc.、Abbott laboratories、Abraxis pharmaceutical products、Teva parenteral medicines Inc.、X gen pharmaceuticals Inc.） ・結論 |
Histoplasmosis is an infection that occurs from breathing spores of a fungus called Histoplasma capsulatum. Histoplasmosis is a fungal infection that occurs throughout the world. Histoplasma fungus grows as a mold in the soil. The soil that contains the droppings of bat or birds usually contains large amount of this fungus. The people with weakened immune system are usually more prone and increases the risk of being affected or reactivated with histoplasmosis. Usually people very young, old people and people affected with cancer, AIDS or organ transplant have severe symptoms. The people with chronic lung disease such as bronchiectasis or emphysema have high risk of severe pain. The common symptoms of histoplasmosis is fever, chills, cough, chest pain, red skin bumps, mouth sores etc. In some patients suffering from histoplasmosis may spread throughout the body and cause irritation and swelling in response to infection.
Certain symptoms also includes chest pain from swelling in lining of heart, neck stiffness etc. The disease is usually diagnosed with biopsy of lungs, skin, liver or bone marrow. Certain blood and urine test also help in detection histoplasmosis proteins or antibodies of the fungus in body. In some cases doctors also perform Chest CT scan, Chest X-ray, Bronchoscopy etc.
Market Analysis and Insights: Global Histoplasmosis Treatment Market
The global Histoplasmosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Histoplasmosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Histoplasmosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Histoplasmosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Histoplasmosis Treatment market.
Global Histoplasmosis Treatment Scope and Market Size
Histoplasmosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Histoplasmosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Amphotericin B
Itraconazole
Ketoconazole
Other
Segment by Application
Hospitals Pharmacies
Private clinics
Drug stores and retail pharmacy
E-commerce
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bristol Myers Squibb
Sigma tau pharmaceuticals Inc.
Three rivers pharmaceuticals
Astellas pharma US Inc.
Abbott laboratories
Abraxis pharmaceutical products
Teva parenteral medicines Inc.
X gen pharmaceuticals Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Histoplasmosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Amphotericin B
1.2.3 Itraconazole
1.2.4 Ketoconazole
1.2.5 Other
1.3 Market by Application
1.3.1 Global Histoplasmosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals Pharmacies
1.3.3 Private clinics
1.3.4 Drug stores and retail pharmacy
1.3.5 E-commerce
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Histoplasmosis Treatment Market Perspective (2016-2027)
2.2 Histoplasmosis Treatment Growth Trends by Regions
2.2.1 Histoplasmosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Histoplasmosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Histoplasmosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Histoplasmosis Treatment Industry Dynamic
2.3.1 Histoplasmosis Treatment Market Trends
2.3.2 Histoplasmosis Treatment Market Drivers
2.3.3 Histoplasmosis Treatment Market Challenges
2.3.4 Histoplasmosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Histoplasmosis Treatment Players by Revenue
3.1.1 Global Top Histoplasmosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Histoplasmosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Histoplasmosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Histoplasmosis Treatment Revenue
3.4 Global Histoplasmosis Treatment Market Concentration Ratio
3.4.1 Global Histoplasmosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Histoplasmosis Treatment Revenue in 2020
3.5 Histoplasmosis Treatment Key Players Head office and Area Served
3.6 Key Players Histoplasmosis Treatment Product Solution and Service
3.7 Date of Enter into Histoplasmosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Histoplasmosis Treatment Breakdown Data by Type
4.1 Global Histoplasmosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Histoplasmosis Treatment Forecasted Market Size by Type (2022-2027)
5 Histoplasmosis Treatment Breakdown Data by Application
5.1 Global Histoplasmosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Histoplasmosis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Histoplasmosis Treatment Market Size (2016-2027)
6.2 North America Histoplasmosis Treatment Market Size by Type
6.2.1 North America Histoplasmosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Histoplasmosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Histoplasmosis Treatment Market Size by Type (2016-2027)
6.3 North America Histoplasmosis Treatment Market Size by Application
6.3.1 North America Histoplasmosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Histoplasmosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Histoplasmosis Treatment Market Size by Application (2016-2027)
6.4 North America Histoplasmosis Treatment Market Size by Country
6.4.1 North America Histoplasmosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Histoplasmosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Histoplasmosis Treatment Market Size (2016-2027)
7.2 Europe Histoplasmosis Treatment Market Size by Type
7.2.1 Europe Histoplasmosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Histoplasmosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Histoplasmosis Treatment Market Size by Type (2016-2027)
7.3 Europe Histoplasmosis Treatment Market Size by Application
7.3.1 Europe Histoplasmosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Histoplasmosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Histoplasmosis Treatment Market Size by Application (2016-2027)
7.4 Europe Histoplasmosis Treatment Market Size by Country
7.4.1 Europe Histoplasmosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Histoplasmosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Histoplasmosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Histoplasmosis Treatment Market Size by Type
8.2.1 Asia-Pacific Histoplasmosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Histoplasmosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Histoplasmosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Histoplasmosis Treatment Market Size by Application
8.3.1 Asia-Pacific Histoplasmosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Histoplasmosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Histoplasmosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Histoplasmosis Treatment Market Size by Region
8.4.1 Asia-Pacific Histoplasmosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Histoplasmosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Histoplasmosis Treatment Market Size (2016-2027)
9.2 Latin America Histoplasmosis Treatment Market Size by Type
9.2.1 Latin America Histoplasmosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Histoplasmosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Histoplasmosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Histoplasmosis Treatment Market Size by Application
9.3.1 Latin America Histoplasmosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Histoplasmosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Histoplasmosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Histoplasmosis Treatment Market Size by Country
9.4.1 Latin America Histoplasmosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Histoplasmosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Histoplasmosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Histoplasmosis Treatment Market Size by Type
10.2.1 Middle East & Africa Histoplasmosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Histoplasmosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Histoplasmosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Histoplasmosis Treatment Market Size by Application
10.3.1 Middle East & Africa Histoplasmosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Histoplasmosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Histoplasmosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Histoplasmosis Treatment Market Size by Country
10.4.1 Middle East & Africa Histoplasmosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Histoplasmosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Company Details
11.1.2 Bristol Myers Squibb Business Overview
11.1.3 Bristol Myers Squibb Histoplasmosis Treatment Introduction
11.1.4 Bristol Myers Squibb Revenue in Histoplasmosis Treatment Business (2016-2021)
11.1.5 Bristol Myers Squibb Recent Development
11.2 Sigma tau pharmaceuticals Inc.
11.2.1 Sigma tau pharmaceuticals Inc. Company Details
11.2.2 Sigma tau pharmaceuticals Inc. Business Overview
11.2.3 Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Introduction
11.2.4 Sigma tau pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2016-2021)
11.2.5 Sigma tau pharmaceuticals Inc. Recent Development
11.3 Three rivers pharmaceuticals
11.3.1 Three rivers pharmaceuticals Company Details
11.3.2 Three rivers pharmaceuticals Business Overview
11.3.3 Three rivers pharmaceuticals Histoplasmosis Treatment Introduction
11.3.4 Three rivers pharmaceuticals Revenue in Histoplasmosis Treatment Business (2016-2021)
11.3.5 Three rivers pharmaceuticals Recent Development
11.4 Astellas pharma US Inc.
11.4.1 Astellas pharma US Inc. Company Details
11.4.2 Astellas pharma US Inc. Business Overview
11.4.3 Astellas pharma US Inc. Histoplasmosis Treatment Introduction
11.4.4 Astellas pharma US Inc. Revenue in Histoplasmosis Treatment Business (2016-2021)
11.4.5 Astellas pharma US Inc. Recent Development
11.5 Abbott laboratories
11.5.1 Abbott laboratories Company Details
11.5.2 Abbott laboratories Business Overview
11.5.3 Abbott laboratories Histoplasmosis Treatment Introduction
11.5.4 Abbott laboratories Revenue in Histoplasmosis Treatment Business (2016-2021)
11.5.5 Abbott laboratories Recent Development
11.6 Abraxis pharmaceutical products
11.6.1 Abraxis pharmaceutical products Company Details
11.6.2 Abraxis pharmaceutical products Business Overview
11.6.3 Abraxis pharmaceutical products Histoplasmosis Treatment Introduction
11.6.4 Abraxis pharmaceutical products Revenue in Histoplasmosis Treatment Business (2016-2021)
11.6.5 Abraxis pharmaceutical products Recent Development
11.7 Teva parenteral medicines Inc.
11.7.1 Teva parenteral medicines Inc. Company Details
11.7.2 Teva parenteral medicines Inc. Business Overview
11.7.3 Teva parenteral medicines Inc. Histoplasmosis Treatment Introduction
11.7.4 Teva parenteral medicines Inc. Revenue in Histoplasmosis Treatment Business (2016-2021)
11.7.5 Teva parenteral medicines Inc. Recent Development
11.8 X gen pharmaceuticals Inc.
11.8.1 X gen pharmaceuticals Inc. Company Details
11.8.2 X gen pharmaceuticals Inc. Business Overview
11.8.3 X gen pharmaceuticals Inc. Histoplasmosis Treatment Introduction
11.8.4 X gen pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2016-2021)
11.8.5 X gen pharmaceuticals Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Histoplasmosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Amphotericin B
Table 3. Key Players of Itraconazole
Table 4. Key Players of Ketoconazole
Table 5. Key Players of Other
Table 6. Global Histoplasmosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Histoplasmosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Histoplasmosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Histoplasmosis Treatment Market Share by Regions (2016-2021)
Table 10. Global Histoplasmosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Histoplasmosis Treatment Market Share by Regions (2022-2027)
Table 12. Histoplasmosis Treatment Market Trends
Table 13. Histoplasmosis Treatment Market Drivers
Table 14. Histoplasmosis Treatment Market Challenges
Table 15. Histoplasmosis Treatment Market Restraints
Table 16. Global Histoplasmosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Histoplasmosis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Histoplasmosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Histoplasmosis Treatment as of 2020)
Table 19. Ranking of Global Top Histoplasmosis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Histoplasmosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Histoplasmosis Treatment Product Solution and Service
Table 23. Date of Enter into Histoplasmosis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Histoplasmosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Histoplasmosis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Histoplasmosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Histoplasmosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Histoplasmosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Histoplasmosis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Histoplasmosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Histoplasmosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Histoplasmosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Histoplasmosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Histoplasmosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Histoplasmosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Histoplasmosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Histoplasmosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Histoplasmosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Histoplasmosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Histoplasmosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Histoplasmosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Histoplasmosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Histoplasmosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Histoplasmosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Histoplasmosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Histoplasmosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Histoplasmosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Histoplasmosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Histoplasmosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Histoplasmosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Histoplasmosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Histoplasmosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Histoplasmosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Histoplasmosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Histoplasmosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Histoplasmosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Histoplasmosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Histoplasmosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Histoplasmosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Histoplasmosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Histoplasmosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bristol Myers Squibb Company Details
Table 64. Bristol Myers Squibb Business Overview
Table 65. Bristol Myers Squibb Histoplasmosis Treatment Product
Table 66. Bristol Myers Squibb Revenue in Histoplasmosis Treatment Business (2016-2021) & (US$ Million)
Table 67. Bristol Myers Squibb Recent Development
Table 68. Sigma tau pharmaceuticals Inc. Company Details
Table 69. Sigma tau pharmaceuticals Inc. Business Overview
Table 70. Sigma tau pharmaceuticals Inc. Histoplasmosis Treatment Product
Table 71. Sigma tau pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2016-2021) & (US$ Million)
Table 72. Sigma tau pharmaceuticals Inc. Recent Development
Table 73. Three rivers pharmaceuticals Company Details
Table 74. Three rivers pharmaceuticals Business Overview
Table 75. Three rivers pharmaceuticals Histoplasmosis Treatment Product
Table 76. Three rivers pharmaceuticals Revenue in Histoplasmosis Treatment Business (2016-2021) & (US$ Million)
Table 77. Three rivers pharmaceuticals Recent Development
Table 78. Astellas pharma US Inc. Company Details
Table 79. Astellas pharma US Inc. Business Overview
Table 80. Astellas pharma US Inc. Histoplasmosis Treatment Product
Table 81. Astellas pharma US Inc. Revenue in Histoplasmosis Treatment Business (2016-2021) & (US$ Million)
Table 82. Astellas pharma US Inc. Recent Development
Table 83. Abbott laboratories Company Details
Table 84. Abbott laboratories Business Overview
Table 85. Abbott laboratories Histoplasmosis Treatment Product
Table 86. Abbott laboratories Revenue in Histoplasmosis Treatment Business (2016-2021) & (US$ Million)
Table 87. Abbott laboratories Recent Development
Table 88. Abraxis pharmaceutical products Company Details
Table 89. Abraxis pharmaceutical products Business Overview
Table 90. Abraxis pharmaceutical products Histoplasmosis Treatment Product
Table 91. Abraxis pharmaceutical products Revenue in Histoplasmosis Treatment Business (2016-2021) & (US$ Million)
Table 92. Abraxis pharmaceutical products Recent Development
Table 93. Teva parenteral medicines Inc. Company Details
Table 94. Teva parenteral medicines Inc. Business Overview
Table 95. Teva parenteral medicines Inc. Histoplasmosis Treatment Product
Table 96. Teva parenteral medicines Inc. Revenue in Histoplasmosis Treatment Business (2016-2021) & (US$ Million)
Table 97. Teva parenteral medicines Inc. Recent Development
Table 98. X gen pharmaceuticals Inc. Company Details
Table 99. X gen pharmaceuticals Inc. Business Overview
Table 100. X gen pharmaceuticals Inc. Revenue in Histoplasmosis Treatment Business (2016-2021) & (US$ Million)
Table 101. X gen pharmaceuticals Inc. Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Histoplasmosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Amphotericin B Features
Figure 3. Itraconazole Features
Figure 4. Ketoconazole Features
Figure 5. Other Features
Figure 6. Global Histoplasmosis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Pharmacies Case Studies
Figure 8. Private clinics Case Studies
Figure 9. Drug stores and retail pharmacy Case Studies
Figure 10. E-commerce Case Studies
Figure 11. Histoplasmosis Treatment Report Years Considered
Figure 12. Global Histoplasmosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Histoplasmosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Histoplasmosis Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Histoplasmosis Treatment Market Share by Regions (2022-2027)
Figure 16. Global Histoplasmosis Treatment Market Share by Players in 2020
Figure 17. Global Top Histoplasmosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Histoplasmosis Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Histoplasmosis Treatment Revenue in 2020
Figure 19. Global Histoplasmosis Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Histoplasmosis Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Histoplasmosis Treatment Market Share by Type (2016-2027)
Figure 23. North America Histoplasmosis Treatment Market Share by Application (2016-2027)
Figure 24. North America Histoplasmosis Treatment Market Share by Country (2016-2027)
Figure 25. United States Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Histoplasmosis Treatment Market Share by Type (2016-2027)
Figure 29. Europe Histoplasmosis Treatment Market Share by Application (2016-2027)
Figure 30. Europe Histoplasmosis Treatment Market Share by Country (2016-2027)
Figure 31. Germany Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Histoplasmosis Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Histoplasmosis Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Histoplasmosis Treatment Market Share by Region (2016-2027)
Figure 41. China Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Histoplasmosis Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Histoplasmosis Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Histoplasmosis Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Histoplasmosis Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Histoplasmosis Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Histoplasmosis Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Histoplasmosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bristol Myers Squibb Revenue Growth Rate in Histoplasmosis Treatment Business (2016-2021)
Figure 61. Sigma tau pharmaceuticals Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2016-2021)
Figure 62. Three rivers pharmaceuticals Revenue Growth Rate in Histoplasmosis Treatment Business (2016-2021)
Figure 63. Astellas pharma US Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2016-2021)
Figure 64. Abbott laboratories Revenue Growth Rate in Histoplasmosis Treatment Business (2016-2021)
Figure 65. Abraxis pharmaceutical products Revenue Growth Rate in Histoplasmosis Treatment Business (2016-2021)
Figure 66. Teva parenteral medicines Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2016-2021)
Figure 67. X gen pharmaceuticals Inc. Revenue Growth Rate in Histoplasmosis Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のクッシング病治療市場規模・現状・予測（2021年-2027年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…- 世界の滑液包炎治療市場規模・現状・予測（2021年-2027年） Bursitis is a swelling or inflammation of the bursa – a sac filled with a lubricating fluid and located between the tissues such as bone, skin, tendons and muscles. Lubricating fluid helps in reducing the friction, rubbing and irritation upon movement of a joint. Bursitis affects mainly elbow, hip, …
- 世界の尿路感染症治療市場規模・現状・予測（2021年-2027年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 世界のドラベ症候群治療市場規模・現状・予測（2021年-2027年） Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells. Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include …
- 世界の糖尿病性胃不全麻痺治療市場規模・現状・予測（2021年-2027年） Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes. During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes…